(Q39651377)

13 September 2017

title

α-Catenin inhibits glioma cell migration, invasion, and proliferation by suppression of β-catenin transactivation (English)

1 reference

13 September 2017

1 reference

Haitao Ji

1

1 reference

13 September 2017

Ji Wang

2

1 reference

13 September 2017

Bingliang Fang

3

1 reference

13 September 2017

Xuexun Fang

4

1 reference

13 September 2017

Zhimin Lu

5

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20872274

20 July 2024

publication date

26 September 2010

1 reference

full work available at URL

13 September 2017

http://link.springer.com/content/pdf/10.1007/s11060-010-0413-4.pdf

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1007/S11060-010-0413-4

http://link.springer.com/article/10.1007/s11060-010-0413-4/fulltext.html

20 July 2024

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0413-4

http://link.springer.com/content/pdf/10.1007/s11060-010-0413-4

20 July 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S11060-010-0413-4

Journal of Neuro-Oncology

20 July 2024

published in

1 reference

13 September 2017

volume

103

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

445-451

1 reference

Malignant astrocytic glioma: genetics, biology, and paths to treatment

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

The natural history of EGFR and EGFRvIII in glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

Molecular mechanisms of glioma cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

Rational bases for the development of EGFR inhibitors for cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

Mammalian MAP kinase signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

Catenins: keeping cells from getting their signals crossed

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

Wnt/beta-catenin signaling: new (and old) players and new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

Identification of c-MYC as a target of the APC pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

Convergence of Wnt, beta-catenin, and cadherin pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

Wnt/beta-catenin signaling in cerebral cortical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

Bench to bedside and back again: molecular mechanisms of alpha-catenin function and roles in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

Regulation of beta-catenin signaling and maintenance of chondrocyte differentiation by ubiquitin-independent proteasomal degradation of alpha-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

Regulation of epithelial cell migration and tumor formation by beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

Caught up in a Wnt storm: Wnt signaling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

Activation of protein kinase C triggers its ubiquitination and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0413-4

Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation

21 January 2018

1 reference

12 December 2020

Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers

1 reference

12 December 2020

Wnt signaling and cancer

1 reference

12 December 2020

Wnt-independent beta-catenin transactivation in tumor development.

1 reference

12 December 2020

Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII.

1 reference

12 December 2020

Identifiers

DOI

1 reference

release_k76d2yeznnfvbl6ys36broj454

13 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k76d2yeznnfvbl6ys36broj454

24 November 2022

mapped directly with Wikidata item

1 reference